Immediate Impact
2 from Science/Nature 71 standout
Citing Papers
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
2025 Standout
STING orchestrates the neuronal inflammatory stress response in multiple sclerosis
2024 Standout
Works of M. Stojanovic being referenced
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS
2016
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
2012 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| M. Stojanovic | 806 | 55 | 358 | 268 | 18 | 1.0k | |
| Amy Pace | 966 | 23 | 535 | 289 | 15 | 1.2k | |
| Suzanne Gazda | 609 | 54 | 269 | 223 | 13 | 993 | |
| Pierangelo Barbero | 601 | 57 | 395 | 252 | 31 | 916 | |
| A. Guseo | 678 | 48 | 315 | 272 | 24 | 980 | |
| William H. Stuart | 968 | 24 | 335 | 520 | 18 | 1.3k | |
| Peter Alping | 751 | 13 | 337 | 311 | 13 | 913 | |
| Becky Parks | 664 | 68 | 338 | 200 | 30 | 1.1k | |
| E. Verdun | 820 | 19 | 426 | 256 | 24 | 1.1k | |
| Bettina Stubinski | 1113 | 13 | 493 | 306 | 15 | 1.3k | |
| C. H. Polman | 782 | 11 | 371 | 249 | 12 | 896 |
All Works
Loading papers...